KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency
Andrew J. Devine, Noah J. Smith, Rashika Joshi, Brandon Brooks-Patton, Jenna Dunham, Ansley N. Varisco, Emily M. Goodman, Qiang Fan, Basilia Zingarelli, Brian M. Varisco
This study evaluates KF4 anti-CELA1 antibody and purified α1-antitrypsin in preventing emphysema in AAT-deficient mice, finding similar efficacy with no additive benefit when combined.
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · Nov 26, 2024Peer-reviewedPathology